GPRC5A and autosomal dominant polycystic kidney disease: Mechanistically, GPRC5A is thought to modulate intracellular signaling pathways such as cAMP, Wnt/β-catenin, and MAPK, which are known to be dysregulated in ADPKD [154,195].